Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

It was agreed that Scotland should provide its own supply of fractions before undertaking work for the NBTS in England.

Published on: 30 August, 2024

John Watt, of the Scottish National Blood Transfusion Service, reported to the DHSS that a fifth of stored plasma had been processed.

Published on: 30 August, 2024

Dr Maycock wrote to the DHSS to tell them 25,000 litres of plasma per year would be available for fractionation by PFC, to begin in the autumn.

Published on: 30 August, 2024

Dr Maycock estimated BPL/PFL's contribution was 17.5 million international units per annum for England.

Published on: 30 August, 2024

SHHD said that it should be prepared for the PFC to be accepted as a pharmaceutical factory-type development.

Published on: 30 August, 2024

Within his oral evidence to the Inquiry, Dr Peter Foster explained how a fractionation centre should support a population of at least 15 million to be economically viable.

Published on: 30 August, 2024

Within a letter from John Watt to Robert Roberts, John Watt stressed that the plant was considerably underutilised and could process blood to serve a population of around 25 million.

Published on: 30 August, 2024

Within a letter from David Stevenson to A Eason a possible solution was proposed regarding the problem of securing an agreement acceptable to the workforce if asked to run a 24-hour shift system.

Published on: 30 August, 2024

A letter from Alec Parrott to Susan Maunsel stated that "even if all the difficulties in shift working at Liberton could be overcome tomorrow, it would not be regarded as sensible policy to put all our eggs in the Scottish basket as the planners appear to have originally intended."

Published on: 30 August, 2024

In 1981, a trial of shift working was conducted at Edinburgh and it was determined that the CSVM system was capable of continuous operation for periods of at least 120 hours.

Published on: 30 August, 2024

A memo from Dr Archibald McIntyre to Angus Macpherson examined further consideration the possibility that PFC might make a contribution to the supply of factor concentrates in the UK.

Published on: 30 August, 2024

Dr Lane saw PFC as being useful to England only for recovering albumin from time-expired plasma.

Published on: 30 August, 2024

Within "Notes on Feasibility Exercise Performed at Protein Fractionation Centre Liberton" it was stated instead of examining three-shift working patterns, the trial involved two shifts, each of 12 hours.

Published on: 30 August, 2024

Angus MacPherson wrote a letter to John Harley outlining that the necessary building works could be completed in approximately two and a half years.

Published on: 30 August, 2024

John Walker wrote a letter to John Cashman advising a substantial proportion of the £6-7 million identified by Angus MacPherson would be needed to rectify the shortcomings which the Medicines Inspectorate had identified in its processes.

Published on: 25 October, 2024

Within his witness statement to the Inquiry, Dr Peter Foster advised it was known to be unlikely that PFC would begin production before the end of 1973. Construction began in 1971. It continued until 1974.

Published on: 30 August, 2024

Within a Blood Products Laboratory report it was explained if PFC processed plasma to produce Factor 8 for England, then less would be needed to be spent on BPL.

Published on: 30 August, 2024

Professor Tuddenham commented on a legal opinion to the Haemophilia Society, writing "Would the provision of home produced concentrate have reduced the number of HIV infected patients? The answer here must very clearly be 'yes'".

Published on: 30 August, 2024

Professor Edward Tuddenham was asked within his oral evidence to the Inquiry if it remained his view that if self-sufficiency had been achieved, that a considerable number of cases of AIDS would have been avoided, to which he responded yes.

Published on: 30 August, 2024

Professor Michael Makris advised within his witness statement to the Inquiry that he believed that, had the UK been self-sufficient in concentrates, the number of HIV infections in haemophilia patients would have been a lot less.

Published on: 30 August, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2122
  • Page 2123
  • Page 2124
  • Page 2125
  • Current page 2126
  • Page 2127
  • Page 2128
  • Page 2129
  • Page 2130
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.